🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

India becomes the fourth country ever to land a spacecraft on the moon. Huge congratulations to ISRO!! So proud! cnn.com/2023/08/23/wor…

Another newly minted PhD from the DGlab. Congrats Dr. Daniel Muliaditan Daniel Muliaditan!! It's been awesome working with you!

Excited to announce the SpACE-Dx joint lab with Nanostring and Next Level Genomics that'll focus on the development & discovery of novel biomarkers & therapeutic targets using spatial multiomics for early interventions/screening strategies. #spatialbiology investors.nanostring.com/news/news-deta…

Insights into the immunological signature of Chronic Hepatitis B and functional cure. Years of hardwork, some great science and collaborations. Ramanuj Dasgupta Niranjan Seng Gee Lim khAT giridharan periyasamy #Hepatitisb Journal of Hepatology #singlecell #immune A*STAR Research

Awesome collaborative effort on defining the single cell landscape of CHB resolution, and the role of CD4-CTLs and innate immunity in driving functional cure. Congrats to Narmada B C khAT Niranjan Seng Gee Lim and team!! sciencedirect.com/science/articl…

🆕Article in press❕ Single cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity #OpenAccess here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Great work in collaboration with Ramanuj Dasgupta understanding the immune landscape of functional cure from CHB!

Functional cure of chronic HBV infection linked to emergence of cytotoxic CD4 T, activated liver-resident NK cells, specific Kupffer cell subtypes and marginated neutrophils Journal of Hepatology Ramanuj Dasgupta doi.org/10.1016/j.jhep…

Super excited about our paper in The EMBO Journal. This work was lead by my brilliant graduate student Uttkarsh. We report that there is a metabolic compartment separation between epidermal keratinocytes and macrophages that exacerbates sterile inflammation! iBRIC-inStem

Absolutely thrilled to share that my Ph.D. work is now published The EMBO Journal. Many thanks to my PI Dr. Srikala Raghavan, colleagues, friends, and family. We show that chronic inflammatory skin diseases are exacerbated by an immune-epithelial metabolic crosstalk. 🧵(1/n)

Humbled and grateful for this editorial on our study defining the single cell landscape of functionally cured chronic Hep B patients. Congrats again Narmada B C khAT Niranjan!! journal-of-hepatology.eu/article/S0168-…

Looking forward to an exciting few days of awesome science at the Multi-Omics meeting, Brisbane. Thanks Arutha K for being such an amazing host!!

pubmed.ncbi.nlm.nih.gov/39622638/ Happy to share Daniel Muliaditan's work with Lih Feng's lab at NUS, where we employ snCut&Run to demonstrate how intratumor epigenetic heterogeneity can predispose subclonal populations to adapt to distinct selective pressures to drive tumor progression.

Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic NPC: a randomised, open-label, phase 2 trial - The Lancet Oncology thelancet.com/journals/lanon… Super excited to be part of this story with Prof. Goh Boon Cher. Stay tuned for more...!

🚨Subgroups left us speechless 🤯 Natalie Fisher of Queen's University Belfast 🎓 gave a fascinating talk on distinct transcriptional and phenotypic states within colorectal polyps! #BowelCancer #ColorectalCancer #Research #CRCThemeDay2025

Online now: CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer dlvr.it/TJzNtX

cell.com/cell-reports-m… Excited to share this latest study from the lab. Kudos to Shumei and the team on establishing a precision oncology paradigm (CAN-Scan) with real-world impact and significance for colorectal cancer patients in the clinic.

Thrilled to share our latest collaboration with Ramanuj Dasgupta's lab! Chayaporn Nok Suphavilai Rafael Peres CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer: Cell Reports Medicine cell.com/cell-reports-m…